About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

About Market Research Forecast

North America Psoriasis Treatment Market

North America Psoriasis Treatment Market Future-Proof Strategies: Market Trends 2025-2033

North America Psoriasis Treatment Market by Drug Class (TNF Inhibitors, Interleukins, Others), by Type (Plaque Psoriasis, Psoriatic Arthritis, Others), by Route of Administration (Oral, Parenteral/Systemic, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by North America (United States, Canada, Mexico) Forecast 2026-2034

Oct 28 2025

Base Year: 2025

113 Pages

North America Psoriasis Treatment Market Future-Proof Strategies: Market Trends 2025-2033

Key Insights

The size of the North America Psoriasis Treatment Market was valued at USD 19.03 USD billion in 2023 and is projected to reach USD 36.38 USD billion by 2032, with an expected CAGR of 9.7% during the forecast period. Psoriasis is a chronic autoimmune skin condition characterized by the rapid buildup of skin cells, leading to scaling, inflammation, redness, and itching. Effective treatment for psoriasis focuses on managing symptoms and preventing flare-ups. Common approaches include topical treatments like corticosteroids, vitamin D analogs, and salicylic acid to reduce inflammation and scaling. Phototherapy, involving controlled exposure to ultraviolet (UV) light, is often recommended for moderate to severe cases. Systemic treatments, such as oral or injectable medications like methotrexate, cyclosporine, or biologics targeting specific immune pathways (e.g., TNF inhibitors, IL-17 or IL-23 inhibitors), are used for severe or treatment-resistant psoriasis. Lifestyle adjustments, including stress management, a balanced diet, and avoiding triggers like smoking or alcohol, can also help improve outcomes.

North America Psoriasis Treatment Market Trends

The North American psoriasis treatment market is characterized by dynamic shifts and evolving patient care philosophies. Key trends shaping the landscape include:

North America Psoriasis Treatment Market Market Size and Forecast (2024-2030) — North America Psoriasis Treatment Market Company Market Share

Driving Forces: What's Propelling the North America Psoriasis Treatment Market

Breakthroughs in Research and Development: Continuous innovation in understanding the underlying mechanisms of psoriasis fuels the development of novel therapeutic targets and more effective, safer treatment options, including new classes of biologics and small molecules.

Increasing Disease Prevalence and Awareness: A growing number of diagnosed cases, coupled with heightened public and physician awareness about psoriasis and its impact, contributes to a larger patient pool seeking advanced treatment solutions.

Robust Healthcare Infrastructure and Access: Well-established healthcare systems and expanding access to specialized dermatological care across North America ensure that a greater number of patients can receive timely and appropriate treatments.

Supportive Reimbursement Landscape and Payer Initiatives: Favorable insurance coverage policies, government programs, and evolving reimbursement strategies for innovative therapies make advanced treatments more accessible and affordable for a wider patient population.

Active Patient Advocacy and Support Networks: Powerful patient advocacy groups play a crucial role in raising disease awareness, driving research funding, advocating for policy changes, and providing vital support to patients, ultimately influencing treatment choices and market demand.

Challenges and Restraints in North America Psoriasis Treatment Market

High Treatment Costs: The cost of psoriasis treatments, especially biologics, can be a barrier to access.
Treatment Resistance: Some patients experience resistance to available treatments, limiting therapeutic options.
Side Effects and Safety Concerns: Biologic therapies may be associated with potential side effects, requiring careful monitoring.
Lack of Universal Treatment Regimen: The optimal treatment for psoriasis varies between individuals, posing a challenge for healthcare providers.
Limited Access in Underserved Areas: Rural and low-income communities may have limited access to specialized psoriasis care.

Key Region or Country & Segment to Dominate the Market

Dominant Region: The United States is projected to maintain its lead in the North American psoriasis treatment market. This dominance is attributed to its extensive patient population, high reported prevalence of psoriasis, substantial investment in pharmaceutical R&D, sophisticated healthcare infrastructure, and robust adoption of cutting-edge therapies.

Dominant Segment: The biologics segment is expected to continue its stronghold and exhibit significant growth. Biologics, including monoclonal antibodies and fusion proteins, offer high efficacy for moderate to severe cases and are increasingly being prescribed due to their targeted mechanisms and favorable long-term safety profiles.

Emerging Segment: The oral medication segment is poised for substantial expansion. The development of new oral small molecules and the increasing acceptance of existing oral therapies are making them a preferred choice for many patients due to their convenience, ease of administration, and growing efficacy, presenting a strong alternative to injectables.

Growth Catalysts in North America Psoriasis Treatment Industry

Innovation in Drug Delivery Systems: Advancements in drug delivery systems, such as transdermal patches and nanoparticles, enhance medication absorption and effectiveness.
Growing Telehealth Adoption: Telehealth platforms facilitate remote patient consultations, medication management, and support group connections.
Personalized Medicine: Genetic testing and biomarkers help identify the most effective treatment for individual patients, optimizing outcomes.
Increased Focus on Patient Education: Patient education programs empower individuals to manage their psoriasis proactively and improve self-care practices.
Government Initiatives and Funding: Government support for research, awareness campaigns, and patient assistance programs fosters market growth.

North America Psoriasis Treatment Market Segmentation

1. Drug Class
- 1.1. TNF Inhibitors
- 1.2. Interleukins
- 1.3. Others
2. Type
- 2.1. Plaque Psoriasis
- 2.2. Psoriatic Arthritis
- 2.3. Others
3. Route of Administration
- 3.1. Oral, Parenteral/Systemic, and Topical
  - 3.1.1. Branded and Generics
4. Distribution Channel
- 4.1. Hospital Pharmacies
- 4.2. Retail Pharmacies
- 4.3. Online Pharmacies

Leading Players in the North America Psoriasis Treatment Market

Significant Developments in North America Psoriasis Treatment Sector

January 2024: Johnson & Johnson Services, Inc. presented positive findings from a Phase 3b study of TREMFYA (guselkumab), highlighting its significant efficacy in treating severe scalp psoriasis, further expanding the therapeutic options for this challenging presentation of the disease.

October 2023: Pfizer, Inc. announced a major milestone with the U.S. FDA approval of ABRILADA (adalimumab-afzb) as an interchangeable biosimilar to Humira, enhancing patient access to a well-established treatment option for psoriasis at potentially lower costs.

July 2023: AbbVie, Inc. revealed compelling results from a Phase 4 head-to-head study of SKYRIZI (risankizumab) against Apremilast, demonstrating SKYRIZI's superior efficacy in managing plaque psoriasis, reinforcing its position as a leading biologic therapy.

December 2021: Amgen Inc. reported encouraging clinical outcomes from a pivotal Phase 3 study evaluating Otezla (apremilast) for moderate to severe plaque psoriasis, underscoring its continued relevance and efficacy in the treatment landscape.

July 2020: Johnson & Johnson Services, Inc. secured U.S. FDA approval for Stelara (ustekinumab) for the treatment of mild to moderate plaque psoriasis in pediatric patients aged 6-11 years, marking a significant step in extending effective psoriasis treatment to younger age groups.

Comprehensive Coverage North America Psoriasis Treatment Market Report

Market Segmentation:

Market size and forecast by drug class, type, route of administration, and distribution channel
Analysis of emerging and niche segments with high growth potential

Geographic Analysis:

In-depth analysis of the North American market, with a focus on key countries like the United States, Canada, and Mexico
Identification of growth opportunities in key regions and emerging markets

Competitive Landscape:

Comprehensive profiles of major players in the market
Analysis of market share, strategies, and competitive dynamics
Insights into mergers, acquisitions, and partnerships shaping the industry

Industry Trends and Forecast:

Analysis of industry trends, including advancements in drug development, regulatory changes, and market dynamics
Forecast of market size and growth for the coming years
Identification of key drivers and challenges impacting the industry

DROCT

The Detailed Report of North America Psoriasis Treatment Market includes:

Executive Summary
Market Dynamics
Segmentation Analysis
Competitive Landscape
Geographic Analysis
Industry Outlook and Forecast
Appendix

Pricing Analysis

The report provides a comprehensive analysis of pricing trends in the North American psoriasis treatment market, including:

Historical and current pricing data for different drug classes and brands
Analysis of factors influencing pricing, such as research and development costs, manufacturing costs, and payer negotiations
Forecast of future pricing trends

Import And Export Analysis

The report provides detailed insights into the import and export dynamics of the North American psoriasis treatment market, including:

Analysis of import and export volumes, values, and trends
Identification of major import and export markets
Analysis of trade regulations and tariffs impacting the market

Patent/Trademark Analysis

The report provides a comprehensive analysis of patents and trademarks in the North American psoriasis treatment market, including:

Analysis of key patents and trademarks held by major players
Identification of patent expiration dates and potential generic competition
Assessment of the impact of intellectual property on market dynamics

Geographic Coverage of North America Psoriasis Treatment Market

Higher Coverage

Lower Coverage

No Coverage

North America Psoriasis Treatment Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 9.7% from 2020-2034
Segmentation	By Drug Class TNF Inhibitors Interleukins Others By Type Plaque Psoriasis Psoriatic Arthritis Others By Route of Administration Oral, Parenteral/Systemic, and Topical Branded and Generics By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies By Geography North America United States Canada Mexico

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Growing Prevalence of Psoriasis in North America to Boost Market Growth
- - 3.3. Market Restrains
  - - 3.3.1. Growing Prevalence of Psoriasis in North America to Boost Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Growing Prevalence of Psoriasis in North America to Boost Market Growth
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Drug Class
  - 5.1.1. TNF Inhibitors
  - 5.1.2. Interleukins
  - 5.1.3. Others
- 5.2. Market Analysis, Insights and Forecast - by Type
  - 5.2.1. Plaque Psoriasis
  - 5.2.2. Psoriatic Arthritis
  - 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - by Route of Administration
  - 5.3.1. Oral, Parenteral/Systemic, and Topical
    - 5.3.1.1. Branded and Generics
- 5.4. Market Analysis, Insights and Forecast - by Distribution Channel
  - 5.4.1. Hospital Pharmacies
  - 5.4.2. Retail Pharmacies
  - 5.4.3. Online Pharmacies
- 5.5. Market Analysis, Insights and Forecast - by Region
  - 5.5.1. North America
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 AbbVie Inc. (U.S.)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Novartis AG (Switzerland)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Johnson & Johnson Services Inc. (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Pfizer Inc. (U.S.)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 LEO Pharma A/S (Denmark)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Merck & Co. Inc. (U.S.)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Amgen Inc. (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Eli Lilly and Company (U.S.)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 Evelo Biosciences Inc. (U.S.)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)

List of Figures

Figure 1: North America Psoriasis Treatment Market Revenue Breakdown (USD billion, %) by Product 2025 & 2033
Figure 2: North America Psoriasis Treatment Market Share (%) by Company 2025

List of Tables

Table 1: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2020 & 2033
Table 2: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2020 & 2033
Table 3: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2020 & 2033
Table 4: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
Table 5: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Region 2020 & 2033
Table 6: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2020 & 2033
Table 7: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2020 & 2033
Table 8: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2020 & 2033
Table 9: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
Table 10: North America Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2020 & 2033
Table 11: United States North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
Table 12: Canada North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033
Table 13: Mexico North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the North America Psoriasis Treatment Market?

The projected CAGR is approximately 9.7%.

2. Which companies are prominent players in the North America Psoriasis Treatment Market?

Key companies in the market include AbbVie, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.), LEO Pharma A/S (Denmark), Merck & Co., Inc. (U.S.), Amgen Inc. (U.S.), Eli Lilly and Company (U.S.), Evelo Biosciences, Inc. (U.S.).

3. What are the main segments of the North America Psoriasis Treatment Market?

The market segments include Drug Class, Type, Route of Administration, Distribution Channel.

4. Can you provide details about the market size?

The market size is estimated to be USD 19.03 USD billion as of 2022.

5. What are some drivers contributing to market growth?

Growing Prevalence of Psoriasis in North America to Boost Market Growth.

6. What are the notable trends driving market growth?

Growing Prevalence of Psoriasis in North America to Boost Market Growth.

7. Are there any restraints impacting market growth?

Growing Prevalence of Psoriasis in North America to Boost Market Growth.

8. Can you provide examples of recent developments in the market?

January 2024 - Johnson & Johnson Services, Inc. completed the Phase 3b VISIBLE study of TREMFYA (guselkumab), evaluating its efficacy in the treatment of severe scalp psoriasis. This study's results were presented at the Maui Derm Hawaii conference in 2024.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3850, USD 4850, and USD 5850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD billion.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "North America Psoriasis Treatment Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the North America Psoriasis Treatment Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the North America Psoriasis Treatment Market?

To stay informed about further developments, trends, and reports in the North America Psoriasis Treatment Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

U.S. Psoriasis Treatment Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

Psoriatic Arthritis Treatment Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Psoriasis Treatment Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

Psoriasis Biologics Drugs Analysis Report 2025: Market to Grow by a CAGR of 5 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Psoriasis Treatment Drugs 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report